Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Next Generation Sequencers market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Next Generation Sequencers market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Sequencing by Synthesis (SBS) Ion Semiconductor Sequencing Sequencing by Ligation (SBL) Pyrosequencing Single-Molecule Real-time (SMRT) Sequencing Other Segmented by End User/Segment Diagnostics Drug Discovery Biomarker Discovery Personalized Medicine Agriculture and Animal Research Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Thermo Fisher Scientific, Inc. (US) Roche Holding AG (Switzerland) QIAGEN N. V. (Germany) Pacific Biosciences of California, Inc. (US) Oxford Nanopore Technologies, Ltd. (UK) Otogenetics Corporation (US) Macrogen Inc. (South Korea) Illumina, Inc. (US) Eurofins Scientific (Luxembourg) BGI (China)

List of Figures

Figure Next Generation Sequencers Picture
Figure Global Next Generation Sequencers Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Next Generation Sequencers Sales Value CAGR (2020-2027) by Region
Figure Global Next Generation Sequencers Sales Value Market Share by Company, 2020
Figure Product Picture of Sequencing by Synthesis (SBS)
Figure Product Picture of Ion Semiconductor Sequencing
Figure Product Picture of Sequencing by Ligation (SBL)
Figure Product Picture of Pyrosequencing
Figure Product Picture of Single-Molecule Real-time (SMRT) Sequencing
Figure Product Picture of Other
Figure Global Next Generation Sequencers Sales Value Market Share by Category, 2020
Figure North America Next Generation Sequencers Sales Value Market Share by Category, 2020
Figure Europe Next Generation Sequencers Sales Value Market Share by Category, 2020
Figure Asia Pacific Next Generation Sequencers Sales Value Market Share by Category, 2020
Figure Central & South America Next Generation Sequencers Sales Value Market Share by Category, 2020
Figure Middle East & Africa Next Generation Sequencers Sales Value Market Share by Category, 2020
Figure Next Generation Sequencers in Diagnostics
Figure Global Next Generation Sequencers Market: Diagnostics (2016-2021)
Figure Next Generation Sequencers in Drug Discovery
Figure Global Next Generation Sequencers Market: Drug Discovery (2016-2021)
Figure Next Generation Sequencers in Biomarker Discovery
Figure Global Next Generation Sequencers Market: Biomarker Discovery (2016-2021)
Figure Next Generation Sequencers in Personalized Medicine
Figure Global Next Generation Sequencers Market: Personalized Medicine (2016-2021)
Figure Next Generation Sequencers in Agriculture and Animal Research
Figure Global Next Generation Sequencers Market: Agriculture and Animal Research (2016-2021)
Figure Next Generation Sequencers in Others
Figure Global Next Generation Sequencers Sales Value Market Share by End User/Segment, 2020
Figure North America Next Generation Sequencers Sales Value Market Share by End User/Segment, 2020
Figure Europe Next Generation Sequencers Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Next Generation Sequencers Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Next Generation Sequencers Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Next Generation Sequencers Sales Value Market Share by End User/Segment, 2020
Figure Global Next Generation Sequencers Sales Value Market Share by Region (2016-2021)
Figure North America Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)
Figure Europe Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)
Figure North America Next Generation Sequencers Sales Value Market Share by Country, 2020
Figure United States Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)
Figure Canada Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)
Figure Mexico Next Generation Sequencers Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Next Generation Sequencers Market Status and Forecast (2016-2027) 1.3.2 Global Next Generation Sequencers Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Next Generation Sequencers Supply by Company 2.1 Global Next Generation Sequencers Sales Value by Company 2.2 Next Generation Sequencers Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Next Generation Sequencers Market Status by Category 3.1 Next Generation Sequencers Category Introduction 3.1.1 Sequencing by Synthesis (SBS) 3.1.2 Ion Semiconductor Sequencing 3.1.3 Sequencing by Ligation (SBL) 3.1.4 Pyrosequencing 3.1.5 Single-Molecule Real-time (SMRT) Sequencing 3.1.6 Other 3.2 Global Next Generation Sequencers Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Next Generation Sequencers Market Status by End User/Segment 4.1 Next Generation Sequencers Segment by End User/Segment 4.1.1 Diagnostics 4.1.2 Drug Discovery 4.1.3 Biomarker Discovery 4.1.4 Personalized Medicine 4.1.5 Agriculture and Animal Research 4.1.6 Others 4.2 Global Next Generation Sequencers Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Next Generation Sequencers Market Status by Region 5.1 Global Next Generation Sequencers Market by Region 5.2 North America Next Generation Sequencers Market Status 5.3 Europe Next Generation Sequencers Market Status 5.4 Asia Pacific Next Generation Sequencers Market Status 5.5 Central & South America Next Generation Sequencers Market Status 5.6 Middle East & Africa Next Generation Sequencers Market Status6 North America Next Generation Sequencers Market Status 6.1 North America Next Generation Sequencers Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Next Generation Sequencers Market Status 7.1 Europe Next Generation Sequencers Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Next Generation Sequencers Market Status 8.1 Asia Pacific Next Generation Sequencers Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Next Generation Sequencers Market Status 9.1 Central & South America Next Generation Sequencers Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Next Generation Sequencers Market Status 10.1 Middle East & Africa Next Generation Sequencers Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Next Generation Sequencers Market Forecast by Category and by End User/Segment 12.1 Global Next Generation Sequencers Sales Value Forecast (2022-2027) 12.2 Global Next Generation Sequencers Forecast by Category 12.3 Global Next Generation Sequencers Forecast by End User/Segment13 Global Next Generation Sequencers Market Forecast by Region/Country 13.1 Global Next Generation Sequencers Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Thermo Fisher Scientific, Inc. (US) 14.1.1 Company Information 14.1.2 Next Generation Sequencers Product Introduction 14.1.3 Thermo Fisher Scientific, Inc. (US) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Roche Holding AG (Switzerland) 14.2.1 Company Information 14.2.2 Next Generation Sequencers Product Introduction 14.2.3 Roche Holding AG (Switzerland) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 QIAGEN N. V. (Germany) 14.3.1 Company Information 14.3.2 Next Generation Sequencers Product Introduction 14.3.3 QIAGEN N. V. (Germany) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Pacific Biosciences of California, Inc. (US) 14.4.1 Company Information 14.4.2 Next Generation Sequencers Product Introduction 14.4.3 Pacific Biosciences of California, Inc. (US) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Oxford Nanopore Technologies, Ltd. (UK) 14.5.1 Company Information 14.5.2 Next Generation Sequencers Product Introduction 14.5.3 Oxford Nanopore Technologies, Ltd. (UK) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Otogenetics Corporation (US) 14.6.1 Company Information 14.6.2 Next Generation Sequencers Product Introduction 14.6.3 Otogenetics Corporation (US) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Macrogen Inc. (South Korea) 14.7.1 Company Information 14.7.2 Next Generation Sequencers Product Introduction 14.7.3 Macrogen Inc. (South Korea) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Illumina, Inc. (US) 14.8.1 Company Information 14.8.2 Next Generation Sequencers Product Introduction 14.8.3 Illumina, Inc. (US) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Eurofins Scientific (Luxembourg) 14.9.1 Company Information 14.9.2 Next Generation Sequencers Product Introduction 14.9.3 Eurofins Scientific (Luxembourg) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 BGI (China) 14.10.1 Company Information 14.10.2 Next Generation Sequencers Product Introduction 14.10.3 BGI (China) Next Generation Sequencers Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology